- Eliem Therapeutics Announces its Addition to the Russell 2000® and Russell 3000® Indexes
- Eliem Therapeutics Announces the Closing of its Acquisition of Tenet Medicines and Concurrent $120 Million Private Placement
- Eliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private Placement
- Eliem Therapeutics Announces Plans to Explore Strategic Alternatives
Key statistics
On Wednesday, Eliem Therapeutics Inc (ELYM:NMQ) closed at 6.86, 191.91% above the 52 week low of 2.35 set on Dec 11, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 6.76 |
---|---|
High | 6.87 |
Low | 6.69 |
Bid | 6.86 |
Offer | 7.00 |
Previous close | 6.81 |
Average volume | 260.40k |
---|---|
Shares outstanding | 34.65m |
Free float | 27.22m |
P/E (TTM) | -- |
Market cap | 237.71m USD |
EPS (TTM) | -0.5347 USD |
Data delayed at least 15 minutes, as of Jul 03 2024 18:00 BST.
More ▼